World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
16018
World Ranking
2667
National Ranking
1277

John A. Zaia publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John A. Zaia sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 263 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John A. Zaia D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John A. Zaia sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John A. Zaia is affiliated with the City Of Hope National Medical Center in the United States. Their research primarily spans the field of Medicine, with focused subfields in Infectious Diseases, Oncology, Epidemiology, Immunology, and Molecular Biology.

The main topics of their research include:

  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Animal Virus Infections Studies

Among their recent publications are:

  • HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation, 2024, New England Journal of Medicine
  • COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins, 2022, Cell Reports
  • Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants, 2022, iScience
  • Large-scale manufacturing and characterization of CMV-CD19CAR T cells, 2022, Journal for ImmunoTherapy of Cancer
  • Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine, 2022, Molecular Therapy - Methods & Clinical Development

Their frequent co-authors include:

  • Stephen J. Forman (12 collaborations)
  • Sanjeet Dadwal (8 collaborations)
  • Sandra Ortega-Francisco (8 collaborations)
  • Ryotaro Nakamura (8 collaborations)
  • Don J. Diamond (7 collaborations)

John A. Zaia has published often in the following venues:

  • Blood (3 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (3 publications)
  • Cytotherapy (3 publications)
  • New England Journal of Medicine (1 publication)
  • Cell Reports (1 publication)

Best Publications

  • Ribozymes as potential anti-HIV-1 therapeutic agents.

    Nava Sarver;Edouard M. Cantin;Pairoj S. Chang;Pairoj S. Chang;John A. Zaia

  • A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

    Gerhard M. Schmidt;David A. Horak;Joyce C. Niland;Steven R. Duncan

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

    Michael Boeckh;W.Garrett Nichols;Genovefa Papanicolaou;Robert Rubin

  • Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

    Elizabeth McLaughlin‐Taylor;Hema Pande;Stephen J. Forman;Becky Tanamachi

  • Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

    Balfour Hh;Bean B;Laskin Ol;Ambinder Rf

  • RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

    David L. DiGiusto;Amrita Krishnan;Lijing Li;Haitang Li

  • Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

    Clyde S. Crumpacker;Lowell E. Schnipper;John A. Zaia;Myron J. Levin

  • Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy

    Jiehua Zhou;Haitang Li;Shirley Li;John Zaia

  • Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy

    Ming Jie Li;James Kim;Shirley Li;John Zaia

  • Airborne Transmission of Chickenpox in a Hospital

    Jeanne M. Leclair;John A. Zaia;Myron J. Levin;Richard G. Congdon

  • Prevention of Cytomegalovirus Infection by Cytomegalovirus Immune Globulin After Marrow Transplantation

    J D Meyers;J Leszczynski;J A Zaia;N Flournoy

  • Direct detection of HIV-1 RNA from AIDS and ARC patient samples.

    George J. Murakawa;John A. Zaia;Patricia A. Spallone;Delilah A. Stephens

  • Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.

    John J. Rossi;David Elkins;John A. Zaia;Sean Sullivan

  • Evaluation of Varicella-Zoster Immune Globulin: Protection of Immunosuppressed Children after Household Exposure to Varicella

    J. A. Zaia;M. J. Levin;S. R. Preblud;J. Leszczynski

  • Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs

    Ming Jie Li;Gerhard Bauer;Alessandro Michienzi;Jiing Kuan Yee

  • Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic Cells

    Priscilla Y. Yam;Shulian Li;Jerry Wu;Jun Hu

  • Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.

    Amrita Krishnan;Arturo Molina;John Zaia;David Smith

  • Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases

    Lijing Li;Ludmila Krymskaya;Jianbin Wang;Jill Henley

  • Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.

    Michael Boeckh;Ghislaine M. Gallez-Hawkins;David Myerson;John A. Zaia

Frequent Co-Authors

Stephen J. Forman
Stephen J. Forman City Of Hope National Medical Center
John J. Rossi
John J. Rossi City Of Hope National Medical Center
Don J. Diamond
Don J. Diamond City Of Hope National Medical Center
Simon F. Lacey
Simon F. Lacey University of Pennsylvania
Myron J. Levin
Myron J. Levin University of Colorado Anschutz Medical Campus
Arturo Molina
Arturo Molina Sutro Biopharma
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Karl G. Blume
Karl G. Blume Stanford University
Ramesh Akkina
Ramesh Akkina Colorado State University
Donald B. Kohn
Donald B. Kohn University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, expanding career opportunities often intersect with fields like nursing and healthcare management. Many professionals choose to pursue advanced nursing degrees to complement their immunology background, especially in specialties that demand strong knowledge of immune function and patient care.

Exploring the best psychiatric mental health nurse practitioner programs online can provide a pathway into mental health, where immunological research is increasingly relevant. Mental health NPs work closely with disorders that may have immunological components, blending care and science.

Cost is often a concern, but numerous cheap psych NP programs offer accessible routes to gain these qualifications without financial strain. These programs help bridge the gap between classroom learning and real-world clinical practice.

Once qualified, selecting a specialty impacts earning potential. According to data on highest paid DNP specialties, acute care nurse practitioners and those with specialized certifications tend to command higher salaries, reflecting the advanced expertise required.

For those already working as Family Nurse Practitioners (FNPs), gaining an acute care certification for FNP offers a promising pathway to specialize and expand clinical roles. This transition aligns well with immunology careers focused on acute patient responses and complex care management.

Best Scientists Citing John A. Zaia

Trending Scientists